| Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis M Presta, P Dell’Era, S Mitola, E Moroni, R Ronca, M Rusnati Cytokine & growth factor reviews 16 (2), 159-178, 2005 | 1655 | 2005 |
| Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells V Bronte, E Apolloni, A Cabrelle, R Ronca, P Serafini, P Zamboni, ... Blood, The Journal of the American Society of Hematology 96 (12), 3838-3846, 2000 | 684 | 2000 |
| Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis R Giavazzi, B Sennino, D Coltrini, A Garofalo, R Dossi, R Ronca, ... The American journal of pathology 162 (6), 1913-1926, 2003 | 215 | 2003 |
| Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development P Dell’Era, R Ronca, L Coco, S Nicoli, M Metra, M Presta Circulation research 93 (5), 414-420, 2003 | 190 | 2003 |
| Inflammatory cells and chemokines sustain FGF2-induced angiogenesis M Presta, G Andrés, D Leali, P Dell’Era, R Ronca European cytokine network 20 (2), 39-50, 2009 | 188 | 2009 |
| Tumor angiogenesis revisited: regulators and clinical implications R Ronca, M Benkheil, S Mitola, S Struyf, S Liekens Medicinal research reviews 37 (6), 1231-1274, 2017 | 186 | 2017 |
| Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach M Presta, P Chiodelli, A Giacomini, M Rusnati, R Ronca Pharmacology & therapeutics 179, 171-187, 2017 | 181 | 2017 |
| Genetic vaccination with “self” tyrosinase-related protein 2 causes melanoma eradication but not vitiligo V Bronte, E Apolloni, R Ronca, P Zamboni, WW Overwijk, DR Surman, ... Cancer Research 60 (2), 253-258, 2000 | 169 | 2000 |
| Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapy C Ebbinghaus, R Ronca, M Kaspar, D Grabulovski, A Berndt, H Kosmehl, ... International journal of cancer 116 (2), 304-313, 2005 | 142 | 2005 |
| Heparin derivatives as angiogenesis inhibitors M Presta, D Leali, H Stabile, R Ronca, M Camozzi, L Coco, E Moroni, ... Current pharmaceutical design 9 (7), 553, 2003 | 139 | 2003 |
| Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy R Ronca, A Giacomini, E Di Salle, D Coltrini, K Pagano, L Ragona, ... Cancer cell 28 (2), 225-239, 2015 | 118 | 2015 |
| Blocking the FGF/FGFR system as a⿿ two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy A Giacomini, P Chiodelli, S Matarazzo, M Rusnati, M Presta, R Ronca Pharmacological research 107, 172-185, 2016 | 97 | 2016 |
| Long pentraxin 3: A novel multifaceted player in cancer A Giacomini, GC Ghedini, M Presta, R Ronca Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (1), 53-63, 2018 | 96 | 2018 |
| Future applications of FGF/FGFR inhibitors in cancer GC Ghedini, R Ronca, M Presta, A Giacomini Expert review of anticancer therapy 18 (9), 861-872, 2018 | 94 | 2018 |
| The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis R Ronca, A Giacomini, M Rusnati, M Presta Expert opinion on therapeutic targets 19 (10), 1361-1377, 2015 | 90 | 2015 |
| Long pentraxin-3 inhibits epithelial–mesenchymal transition in melanoma cells R Ronca, E Di Salle, A Giacomini, D Leali, P Alessi, D Coltrini, C Ravelli, ... Molecular cancer therapeutics 12 (12), 2760-2771, 2013 | 85 | 2013 |
| Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 M Presta, E Foglio, A Churruca Schuind, R Ronca Frontiers in immunology 9, 2327, 2018 | 81 | 2018 |
| Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis D Leali, A Inforzato, R Ronca, R Bianchi, M Belleri, D Coltrini, E Di Salle, ... Arteriosclerosis, thrombosis, and vascular biology 32 (3), 696-703, 2012 | 77 | 2012 |
| Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer R Ronca, P Alessi, D Coltrini, E Di Salle, A Giacomini, D Leali, M Corsini, ... The Journal of pathology 230 (2), 228-238, 2013 | 73 | 2013 |
| Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies F Roncato, F Rruga, E Porcù, E Casarin, R Ronca, F Maccarinelli, ... Nature communications 9 (1), 4070, 2018 | 72 | 2018 |
